3 Drugs for an Eye Disease, With Big Price Gaps, Are Found to Be Equals for Many

The three drugs — Eylea, Lucentis and Avastin — are meant to treat a condition known as macular edema, which occurs primarily in patients with diabetes.

Source: NYT Health - February 18, 2015 Category: Consumer Health News Authors: By ANDREW POLLACK Tags: Eyes and Eyesight Roche Holding AG RHHBY Other OTC National Eye Institute Research Eylea (Drug) Regeneron Pharmaceuticals Inc REGN NASDAQ Source Type: news